Migration-stimulating factor as a novel biomarker in salivary gland tumours

2011 ◽  
Vol 40 (10) ◽  
pp. 747-754 ◽  
Author(s):  
Lateef E. Aljorani ◽  
Agnes Bankfalvi ◽  
Frank A. Carey ◽  
Koji Harada ◽  
Go Ohe ◽  
...  
1999 ◽  
Vol 8 (3) ◽  
pp. 201-212
Author(s):  
Mohi Al-Tamami ◽  
Nail Al-Naqeeb ◽  
Agnes Kovacs ◽  
Hussein Dashti ◽  
John Madda Patrick

Author(s):  
Edward Balai ◽  
Navdeep Bhamra ◽  
Karan Jolly

Salivary gland tumours are uncommon and account for just 6% of all head and neck neoplasms. Worldwide incidence varies, from 0.4 to 13.5 cases per 100 000 population. The parotid gland is by far the most commonly affected site, accounting for 80% of cases. The vast majority of these tumours are benign; only approximately 20–25% being malignant. This article considers the relevant clinical anatomy of the parotid gland, key aspects of assessment with history and examination, and when to refer to secondary care for further investigation. It will touch on the common benign and malignant parotid neoplasms and give an overview of secondary care management.


Oral Oncology ◽  
2021 ◽  
Vol 118 ◽  
pp. 3
Author(s):  
Carolina Pereira ◽  
Diana Pessoa ◽  
Miguel Rito ◽  
Teresa Alexandre ◽  
Isabel Sargento ◽  
...  

1987 ◽  
Vol 101 (11) ◽  
pp. 1175-1181 ◽  
Author(s):  
Jae Y. Ro ◽  
Bruce Mackay ◽  
John G. Batsakis ◽  
Joiner Cartwright

AbstractThe ultrastructural, X-ray microanalytical, histochemical and immunocytochemi-cal features of intraluminal crystalloids found in adenocarcinomas of the parotid gland have been studied. The crystalloids, putatively derived from an abnormal crystalization of salivary duct proteins, are considerably different from the crystalloids found in normal parotid glands, pleomorphic adenomas, and sialocysts.


2012 ◽  
Vol 2012 ◽  
pp. 1-6 ◽  
Author(s):  
Grażyna Wyszyńska-Pawelec ◽  
Michał Gontarz ◽  
Jan Zapała ◽  
Mariusz Szuta

The aim of this retrospective study of 56 patients with minor salivary gland tumours (MSGTs) of the upper aerodigestive tract is to present demographic features, distribution of tumours as well as methods and results of treatment performed in our institution over a 10-year period. Of 221 patients with salivary gland tumours, 56 patients with MSGT were selected. There were 36 female and 20 male patients aged from 8 to 81 years. Male-to-female ratio was 1 : 2 in the group of benign MSGT and 1 : 1.7 in the group of malignant tumours. The palate was the most frequent site of MSGT (45.6%), followed by buccal mucosa (19.3%). Of all MSGTs 63.2% were malignant, and 36.8% were benign. Adenoid cystic carcinoma was the most common neoplasm (31.6%), followed by pleomorphic adenoma (29.8%). Surgery was the method of choice in the treatment of patients with MSGT. Postoperative defects were reconstructed by prosthetic obturators, local flaps, and free radial forearm flap. Relative survival for patients with malignant MSGT was 88% at three years and 71.5% at five years. MSGTs are more frequent in females and predominantly affect the palate. Malignant MSGTs are more common than benign.


Sign in / Sign up

Export Citation Format

Share Document